OpenPharmacy
How OpenPharmacy Became the #1 AI-Cited eScript Source in Australia in 30 Days
After a GEO sprint with BrandViz.AI, OpenPharmacy went from zero AI citations to the most cited eScript source in Australia - overtaking funded competitors Scripty and MedAdvisor, and the Australian Digital Health Agency's own website, which had previously dominated the category.
“Honestly, AI visibility was a blind spot for me until a mentor pointed it out. The moment she said ‘people aren’t going to Google for stuff anymore - it’s just going to be what the AI recommends,’ I was like: yeah of course. I immediately knew it needed my attention.
The first report was brutal. But it pointed out the real value and urgent need for what BrandViz is providing.
BrandViz fixed it in 30 days. OpenPharmacy went from zero AI citations across every platform to the #1 cited eScript source in Australia, ahead of funded competitors and the Australian Digital Health Agency's own website. Seeing that gave me genuine peace of mind - it's working as top-of-funnel marketing, and then some.
The content quality and quantity were genuinely impressive. Rushana and David are a formidable team of A-players - more responsive than me sometimes.
The language, the way BrandViz built our brand name throughout every content piece to create authority - I couldn't have done it better myself. Couldn't even have gotten close, honestly.
I got more value than I paid for. Funds are scarce when you're a solo founder, so I hate saying that. You should charge more.
I'm already singing BrandViz's praises to everyone I know.”
30 days. By the numbers.
| Metric | Before the sprint | After the sprint |
|---|---|---|
| Overall AI Visibility Score | 10.1% | 35.8% |
| Own-site citations | 0 | 483 |
| Mentioned vs competitors | #4 (52 mentions) | #1 (297 mentions) |
| ChatGPT citation rate* | 0% | 43% |
| Gemini visibility | 0.8% | 31.6% |
| Gemini citation rate* | 0% | 44% |
| Perplexity visibility | 6.3% | 39.1% |
| Perplexity citation rate* | 0% | 46% |
| Claude visibility | 2.5% | 64.6% |
Baseline: March 3, 2026. Final report: April 4, 2026. 7 reports tracked across 600 AI responses per report.
* Citation rate - out of every 10 relevant questions asked in their category, Gemini was using OpenPharmacy's own website as a source roughly 4 times. Perplexity: ~5 times. ChatGPT: ~4 times.
App downloads continued post-sprint - with no paid acquisition running
After the sprint ended, OpenPharmacy's downloads kept coming in. Jean-Marc attributed the continued inflow directly to the uplift in AI visibility - a channel now working as top-of-funnel marketing with zero ongoing spend.
The founder
OpenPharmacy was founded by Jean-Marc Wicht, a doctor-turned-data-engineer who built the app after forgetting his own prescription on a bus. He trained as a doctor, played music in Europe for three years, completed a master's in financial mathematics, and taught himself to code through corporate Australia before launching OpenPharmacy in December 2025 as an ADHA-conformant eScript wallet: secure, offline-capable, and independent of any pharmacy chain.
By early 2026, he had a solid product, real compliance credentials, and a genuine offline-first differentiator that competitors couldn't match. He also had no AI visibility whatsoever. His competitors were getting recommended. He wasn't.
The moment it clicked
Jean-Marc discovered the AI visibility gap through a mentor at River City Labs, who told him: people aren't going to Google anymore - it's going to be what the AI recommends. He reached out to BrandViz.AI that same evening, they spoke within days, and by March the sprint was underway.
“Honestly, this was a blind spot until Laura mentioned BrandViz and I immediately realized this required my attention.”
Jean-Marc Wicht, founder, OpenPharmacy
What was OpenPharmacy's AI visibility before the sprint?
Before working with BrandViz.AI in March 2026, OpenPharmacy had zero own-site citations across all four major AI platforms: ChatGPT, Gemini, Claude, and Perplexity - together accounting for more than 95% of all AI search traffic. The brand ranked #4 in competitive mentions with 52 citations, while government health websites and competitor pages dominated every response.
The answers to every eScript-related query came from elsewhere. digitalhealth.gov.au led all citations with 372. healthdirect.gov.au followed with 140. Scripty's website had 104. OpenPharmacy's own website: zero. In the baseline report, not a single brand URL appeared in the top 882 cited sources across all platforms.
On Gemini, which handles roughly 35% of AI search traffic, the brand registered 0.8% visibility. The only platform where it appeared meaningfully was ChatGPT, at 17% - and even those citations came from App Store listings, not the website. OpenPharmacy's own content had never once been used as a source by any AI model.
Thanks for the brutal audit report 😅 It points out the real value and urgent need for what you're providing.
How does BrandViz.AI measure AI visibility?
BrandViz.AI measures AI visibility by simulating the buyer journey of a brand's ideal customer across all four major AI platforms - using a question set that the brand itself reviews and approves.
For OpenPharmacy, this meant building 150 questions that mirror what Australian patients, caregivers, and families would ask at each stage of their journey: from early problem recognition ("I keep losing my e-script text messages") through to final vendor evaluation ("Which Australian prescription app works completely offline?"). Jean-Marc reviewed and signed off on the full question set before any measurement began - confirming these were the questions OpenPharmacy actually wanted to be answering for its target customers.
Each question was then run across ChatGPT, Gemini, Claude, and Perplexity to capture where OpenPharmacy appeared, where it didn't, and who was winning in its place. The result is a repeatable before/after measurement built on a structured buyer journey simulation.
What did BrandViz.AI do for OpenPharmacy?
Think of AI visibility like a library. Before the sprint, OpenPharmacy's books weren't on the shelves - the librarian couldn't find them, couldn't read the spines, and there weren't many books to begin with. BrandViz.AI fixed all three: got the books on the shelves, labelled them clearly, and wrote the ones that were missing.
BrandViz.AI's work covered three layers of AI visibility: technical foundation, metadata structure, and content - all in 30 days. No paid media. No backlink campaigns. No product changes. The results are attributable to GEO work alone.
Layer 1 - Crawlability - the foundation everything else depends on
AI crawlers are not browsers. They don't render JavaScript - they hit a URL, read the raw HTML, and move on. No second pass. OpenPharmacy's React site looked perfect to human visitors and was an empty shell to every AI crawler trying to cite it. BrandViz.AI added a pre-rendering step so the site AI models see is the same site humans see. Without this foundation in place, no amount of content or metadata work would have moved the needle - AI simply couldn't get in.
Layer 2 - Metadata - structuring content for AI extraction
AI needs answers immediately, in the paragraph it lands on, self-contained. It won't piece together who you are from across your site. BrandViz.AI added clean, rich metadata across every page - unique descriptive titles, factual meta descriptions, and structured markup - giving crawlers an accurate summary of each page before they even read the body. Every OpenPharmacy page was missing these entirely.
Layer 3 - Content - answering the questions AI is being asked
AI retrieves specific, factual claims - not brand language. "Store your prescription QR codes directly on your device, accessible without any internet connection" gets cited. "The smarter way to manage your scripts" does not.
Every article BrandViz.AI published was built on this foundation: precise answers to specific questions, structured for AI extraction, written to be genuinely useful for human readers, and reviewed for accuracy against Australian digital health regulatory requirements. Topics covered offline access in rural areas, ADHA conformance, family and caregiver prescription management, eScript security standards, and what to do when an eScript SMS token is accidentally deleted.
I just wanted to note that this is amazing work! The quality and quantity is very impressive.
Hey @David and @Rushana. I've reviewed the new content pieces. Absolutely amazing work as always! I couldn't have done it better myself.
Mid-sprint, a GitHub Pages conflict silently de-indexed all new blog pages. Jean-Marc's developer was in Japan - skiing. The BrandViz.AI team diagnosed the cause, pushed a fix within days, and walked Jean-Marc through the resubmission manually. By the end of the sprint he had also taught himself to deploy the website. “I guess you can call me a website expert now.”
What were OpenPharmacy's final results?
On April 4, 2026, OpenPharmacy reached #1 in AI responses for the Australian eScript category, with 483 own-site citations where there had been zero - overtaking Scripty, MedAdvisor, and the Australian Digital Health Agency's official website. In plain terms: when someone asked ChatGPT, Gemini, Claude, or Perplexity about eScript apps in Australia, the answer now consistently came from OpenPharmacy's own website - for exactly the questions OpenPharmacy wanted to show up for.
Jean-Marc's message in the shared Slack channel that morning: "You did it! 🎉"
Hey @David and @Rushana. Saw the latest report. Just wanted to say that you guys are amazing at what you do. Well done!
He had also tested Grok independently, not tracked by BrandViz.AI. Same result. "It's up everywhere," he said.
AI responses are non-deterministic - no two answers are identical. These screenshots were captured during the sprint period. The visibility metrics above reflect aggregated results across hundreds of queries, which is a more reliable signal than any single response.
Which pages drove the most AI citations?
Before the sprint, OpenPharmacy had zero brand URLs in the top cited sources. After the sprint, brand-authored pages held three of the top five citation positions - and for the most critical buyer questions, no competitor was cited alongside them.
| Article |
|---|
| Best eScript Apps in Australia (2026) 178 citations#1 |
| Managing Family eScripts in Australia 85 citations#1 |
| What Is an eScript Wallet? 81 citations#1 |
| Offline eScript Access in Australia 38 citations#1 |
| What Happens If You Delete Your eScript SMS? 15 citations#1 |
The homepage barely registers. This is how AI citation works: structured, targeted content that answers a specific question outperforms a homepage every time.
What changed for OpenPharmacy's business?
After the sprint, OpenPharmacy moved from #4 to #1 in AI mentions across its category, appearing in 95% of offline access queries, 90% of caregiver queries, and 88% of security-focused queries - up from near-zero across all three.
Before the sprint, AI models positioned OpenPharmacy narrowly: occasionally useful for offline access, absent everywhere else. Competitors captured the early-stage conversations where users describe a problem and ask what to do about it. That changed.
“It's a massive blind spot for startups. They're so focused on product they're not thinking about who's already sending people to their competitors instead. I feel like we are first movers here. It's nice to be first.”
Jean-Marc Wicht, founder, OpenPharmacy
After the sprint, OpenPharmacy's app downloads continued with no paid acquisition running. Jean-Marc attributed the continued inflow to the uplift in AI visibility. Google search traffic also increased over the same period - a compounding effect of the same content and technical work.
Before the sprint
After the sprint
Is AI visibility your blind spot?
Jean-Marc didn't know his brand was invisible to AI until a mentor pointed it out. Most founders don't - they're building the product, closing the deals, putting out fires. AI visibility isn't on the list because it isn't visible.
94% of B2B buyers use AI during their purchase journey. The winning vendor is already on the shortlist before the first sales call. In any given category, just five brands capture 80% of all AI-generated responses. One of those five spots in the Australian eScript category now belongs to OpenPharmacy.
Find out where you stand
Get a free AI visibility report across ChatGPT, Claude, Gemini, and Perplexity. 25 buyer queries, no credit card, ready in 10 minutes.
Free report - No credit card - Ready in 10 minutes
Written by
Rushana Maksudova
Co-Founder & CEO
Co-founder and CEO of BrandViz.AI. Former Site Reliability Engineer at Google, where she also designed and led technical training across ten global offices. She now leads GTM, client delivery, and content at BrandViz.AI — helping brands understand and act on the shift from traditional search to AI-driven discovery.
Stay ahead of AI changes
Get original research on how AI recommends brands.
No spam, unsubscribe anytime.